Home/Filings/4/0001140361-25-044554
4//SEC Filing

Fischer David B 4

Accession 0001140361-25-044554

CIK 0000009326other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 4:28 PM ET

Size

13.8 KB

Accession

0001140361-25-044554

Insider Transaction Report

Form 4
Period: 2025-12-03
Transactions
  • Exercise/Conversion

    Common Stock

    2025-12-03$74.57/sh+3,383$252,27013,372 total
  • Exercise/Conversion

    Common Stock

    2025-12-03$84.09/sh+2,617$220,06415,989 total
  • Sale

    Common Stock

    2025-12-03$153.91/sh6,000$923,4589,989 total
  • Sale

    Common Stock

    2025-12-03$154.15/sh2,000$308,2917,989 total
  • Exercise/Conversion

    Stock Options

    2025-12-033,3830 total
    Exercise: $74.57Exp: 2028-02-15Common Stock (3,383 underlying)
  • Exercise/Conversion

    Stock Options

    2025-12-032,6170 total
    Exercise: $84.09Exp: 2029-02-13Common Stock (2,617 underlying)
Footnotes (5)
  • [F1]Exercise of fully vested non-qualified stock options.
  • [F2]This transaction was executed in multiple sales ranging from $153.5100 to $154.2400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  • [F3]This transaction was executed in multiple sales ranging from $153.9045 to $154.3400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
  • [F4]Stock options that vested 20% on February 15, 2019, 40% on February 15, 2020, and 40% on February 15, 2021, and are exercisable.
  • [F5]Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable.

Issuer

BALCHEM CORP

CIK 0000009326

Entity typeother

Related Parties

1
  • filerCIK 0001305182

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:28 PM ET
Size
13.8 KB